Sachi Sakaguchi Selected Research

Fetal Proteins (Fetoprotein)

6/2021

Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α-fetoprotein: Outcomes by treatment-emergent ascites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sachi Sakaguchi Research Topics

Disease

6	Neoplasms (Cancer) 09/2019 - 05/2010
5	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2019
3	Neutropenia 09/2021 - 05/2010
2	Disease Progression 01/2023 - 12/2018
2	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 06/2021
2	Pancreatitis 08/2017 - 03/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 06/2008
1	Leukopenia 09/2021
1	Diarrhea 09/2021
1	Ascites 06/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2021
1	Glioma (Gliomas) 09/2019
1	Sarcoma (Soft Tissue Sarcoma) 12/2018
1	Febrile Neutropenia 12/2018
1	Hodgkin Disease (Hodgkin's Disease) 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Pain (Aches) 06/2014
1	Human Influenza (Influenza) 05/2011
1	Ectopic Pregnancy 01/2011
1	Congenital Abnormalities (Deformity) 01/2011
1	Fever (Fevers) 05/2010
1	Back Pain (Backache) 06/2008
1	Hematuria 06/2008
1	Flank Pain 06/2008
1	Urolithiasis 06/2008

Drug/Important Bio-Agent (IBA)

5	abemaciclibIBA 01/2023 - 09/2019
4	Hormones (Hormone)IBA 01/2023 - 09/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2021
2	Fulvestrant (Faslodex)FDA Link 01/2023 - 09/2021
2	Octreotide (Sandostatin)FDA LinkGeneric 08/2017 - 03/2008
2	Asparaginase (Elspar)FDA Link 08/2017 - 03/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 01/2011
1	BilirubinIBA 09/2021
1	Sorafenib (BAY 43-9006)FDA Link 09/2021
1	AlbuminsIBA 09/2021
1	lenvatinibIBA 09/2021
1	Fetal Proteins (Fetoprotein)IBA 06/2021
1	RamucirumabIBA 06/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2019
1	Estrogen ReceptorsIBA 09/2019
1	Estrogens (Estrogen)FDA Link 09/2019
1	olaratumabIBA 12/2018
1	Monoclonal AntibodiesIBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2018
1	Inosine Triphosphate (ITP)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	SteroidsIBA 01/2016
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2016
1	VaccinesIBA 05/2011

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2023 - 06/2008
1	Duration of Therapy 06/2021
1	Maintenance Chemotherapy 01/2016
1	Analgesia 06/2014
1	Pain Management 06/2014
1	Cranial Irradiation 01/2014
1	Aftercare (After-Treatment) 01/2011
1	Induction Chemotherapy 06/2008
1	Consolidation Chemotherapy 06/2008